Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 68 | 2024 | 6855 | 3.950 |
Why?
|
Carcinoma, Pancreatic Ductal | 19 | 2024 | 1720 | 2.110 |
Why?
|
Pancreatic Neoplasms | 31 | 2024 | 5333 | 2.010 |
Why?
|
Tumor Microenvironment | 27 | 2024 | 3826 | 1.640 |
Why?
|
Microsatellite Instability | 26 | 2024 | 715 | 1.570 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 15 | 2024 | 1090 | 1.500 |
Why?
|
Adenocarcinoma | 17 | 2024 | 6310 | 1.370 |
Why?
|
DNA Mismatch Repair | 9 | 2024 | 429 | 1.230 |
Why?
|
Fusobacterium nucleatum | 9 | 2021 | 165 | 1.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 8 | 2024 | 896 | 0.910 |
Why?
|
Colonic Neoplasms | 8 | 2024 | 2526 | 0.850 |
Why?
|
Proto-Oncogene Proteins B-raf | 16 | 2024 | 2052 | 0.810 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2024 | 321 | 0.800 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 13 | 2024 | 1729 | 0.740 |
Why?
|
Mutation | 40 | 2024 | 29950 | 0.730 |
Why?
|
Genes, erbB-2 | 1 | 2020 | 163 | 0.690 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 4 | 2019 | 380 | 0.680 |
Why?
|
Granulocytes | 1 | 2021 | 551 | 0.650 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 311 | 0.620 |
Why?
|
CpG Islands | 7 | 2024 | 1221 | 0.600 |
Why?
|
Receptor, IGF Type 1 | 1 | 2020 | 380 | 0.590 |
Why?
|
DNA Mutational Analysis | 7 | 2024 | 4109 | 0.590 |
Why?
|
Pathology, Molecular | 5 | 2024 | 330 | 0.590 |
Why?
|
Prognosis | 29 | 2024 | 29636 | 0.530 |
Why?
|
DNA Methylation | 16 | 2024 | 4374 | 0.520 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2023 | 3618 | 0.470 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2023 | 612 | 0.420 |
Why?
|
Cell Lineage | 2 | 2020 | 2525 | 0.390 |
Why?
|
Monocytes | 1 | 2021 | 2574 | 0.390 |
Why?
|
Neoplasm Staging | 5 | 2024 | 11141 | 0.380 |
Why?
|
Prospective Studies | 34 | 2024 | 54263 | 0.370 |
Why?
|
DNA, Bacterial | 5 | 2018 | 1455 | 0.350 |
Why?
|
Molecular Targeted Therapy | 3 | 2021 | 2805 | 0.340 |
Why?
|
Humans | 131 | 2024 | 760261 | 0.340 |
Why?
|
Hair Follicle | 2 | 2009 | 211 | 0.340 |
Why?
|
Fusobacterium Infections | 2 | 2021 | 53 | 0.330 |
Why?
|
Diet | 9 | 2024 | 8008 | 0.330 |
Why?
|
Aged | 60 | 2024 | 168995 | 0.310 |
Why?
|
Myeloid Cells | 3 | 2024 | 821 | 0.290 |
Why?
|
Helicobacter pylori | 2 | 2023 | 377 | 0.280 |
Why?
|
Cyclooxygenase 2 | 3 | 2020 | 600 | 0.280 |
Why?
|
Middle Aged | 61 | 2024 | 220175 | 0.280 |
Why?
|
Stem Cells | 3 | 2009 | 3525 | 0.280 |
Why?
|
Immunotherapy | 5 | 2024 | 4637 | 0.280 |
Why?
|
Neoplasms | 9 | 2024 | 22066 | 0.270 |
Why?
|
Germ-Line Mutation | 7 | 2024 | 1843 | 0.270 |
Why?
|
Receptors, Calcium-Sensing | 2 | 2017 | 318 | 0.260 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2024 | 4554 | 0.260 |
Why?
|
Calcium, Dietary | 2 | 2019 | 531 | 0.250 |
Why?
|
Neoadjuvant Therapy | 4 | 2024 | 2811 | 0.250 |
Why?
|
Male | 68 | 2024 | 359413 | 0.250 |
Why?
|
Tumor Escape | 2 | 2018 | 371 | 0.240 |
Why?
|
Female | 71 | 2024 | 391011 | 0.240 |
Why?
|
Carcinoma | 4 | 2017 | 2334 | 0.240 |
Why?
|
Arginase | 1 | 2024 | 80 | 0.220 |
Why?
|
Phenotype | 11 | 2024 | 16543 | 0.220 |
Why?
|
Follow-Up Studies | 24 | 2024 | 39254 | 0.220 |
Why?
|
Deoxycytidine | 2 | 2024 | 872 | 0.220 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 117 | 0.220 |
Why?
|
Proportional Hazards Models | 12 | 2022 | 12532 | 0.220 |
Why?
|
Cell Separation | 1 | 2009 | 1720 | 0.210 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11708 | 0.210 |
Why?
|
Disease-Free Survival | 6 | 2024 | 6830 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 8 | 2024 | 6545 | 0.210 |
Why?
|
Leucovorin | 1 | 2024 | 639 | 0.210 |
Why?
|
HLA-DR Antigens | 2 | 2021 | 630 | 0.210 |
Why?
|
Bacteroides fragilis | 1 | 2024 | 238 | 0.210 |
Why?
|
Rectal Neoplasms | 3 | 2016 | 1151 | 0.210 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 1811 | 0.200 |
Why?
|
Iron-Sulfur Proteins | 1 | 2022 | 83 | 0.200 |
Why?
|
Leukocytes | 2 | 2021 | 2030 | 0.200 |
Why?
|
Metalloendopeptidases | 1 | 2024 | 394 | 0.200 |
Why?
|
Proto-Oncogene Proteins | 4 | 2023 | 4494 | 0.200 |
Why?
|
Epithelial Cells | 3 | 2009 | 3665 | 0.200 |
Why?
|
Helicobacter Infections | 2 | 2023 | 386 | 0.200 |
Why?
|
Keloid | 1 | 2022 | 54 | 0.190 |
Why?
|
DNA Glycosylases | 1 | 2022 | 124 | 0.190 |
Why?
|
Staining and Labeling | 2 | 2020 | 1090 | 0.190 |
Why?
|
Long Interspersed Nucleotide Elements | 3 | 2020 | 330 | 0.190 |
Why?
|
Lymphocytes | 3 | 2020 | 2612 | 0.180 |
Why?
|
Alkylating Agents | 1 | 2021 | 133 | 0.180 |
Why?
|
T-Lymphocytes | 7 | 2024 | 10183 | 0.180 |
Why?
|
Weight Loss | 2 | 2024 | 2683 | 0.180 |
Why?
|
Colitis | 2 | 2020 | 1229 | 0.180 |
Why?
|
Hematoxylin | 1 | 2020 | 60 | 0.180 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2020 | 69 | 0.180 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2004 | 543 | 0.180 |
Why?
|
Survival Analysis | 8 | 2020 | 10185 | 0.180 |
Why?
|
Paclitaxel | 2 | 2024 | 1738 | 0.180 |
Why?
|
Autophagy | 3 | 2022 | 1336 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9274 | 0.170 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2021 | 218 | 0.170 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 208 | 0.170 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 2473 | 0.170 |
Why?
|
Receptors, Chemokine | 2 | 2020 | 654 | 0.170 |
Why?
|
Adult | 38 | 2024 | 219847 | 0.170 |
Why?
|
Fluorouracil | 1 | 2024 | 1630 | 0.170 |
Why?
|
Lymphocyte Count | 5 | 2022 | 780 | 0.160 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.160 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 311 | 0.160 |
Why?
|
Bifidobacteriales Infections | 1 | 2018 | 10 | 0.160 |
Why?
|
Paraffin Embedding | 1 | 2020 | 302 | 0.160 |
Why?
|
Tissue Fixation | 1 | 2020 | 241 | 0.160 |
Why?
|
Lysine | 1 | 2023 | 1002 | 0.160 |
Why?
|
Immunohistochemistry | 8 | 2021 | 11064 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2024 | 8498 | 0.160 |
Why?
|
Microsatellite Repeats | 2 | 2021 | 786 | 0.160 |
Why?
|
Interleukin-1beta | 1 | 2024 | 999 | 0.160 |
Why?
|
Formaldehyde | 1 | 2020 | 358 | 0.150 |
Why?
|
Intestine, Small | 2 | 2021 | 1207 | 0.150 |
Why?
|
Sarcoma | 2 | 2020 | 1786 | 0.150 |
Why?
|
Escherichia coli Infections | 1 | 2022 | 524 | 0.150 |
Why?
|
Bifidobacterium | 1 | 2018 | 98 | 0.150 |
Why?
|
Ribonuclease III | 1 | 2020 | 279 | 0.150 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2018 | 83 | 0.150 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2019 | 557 | 0.150 |
Why?
|
Forkhead Transcription Factors | 3 | 2020 | 1613 | 0.150 |
Why?
|
Macrophage Activation | 1 | 2020 | 553 | 0.150 |
Why?
|
Folic Acid | 1 | 2024 | 1309 | 0.150 |
Why?
|
Colon | 3 | 2020 | 1788 | 0.150 |
Why?
|
Coffee | 1 | 2022 | 582 | 0.140 |
Why?
|
Dairy Products | 1 | 2021 | 494 | 0.140 |
Why?
|
Jews | 1 | 2019 | 364 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2024 | 5230 | 0.140 |
Why?
|
DEAD-box RNA Helicases | 1 | 2020 | 383 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1408 | 0.140 |
Why?
|
Osteosarcoma | 1 | 2023 | 898 | 0.140 |
Why?
|
Incidence | 12 | 2024 | 21378 | 0.140 |
Why?
|
Feeding Behavior | 2 | 2021 | 3185 | 0.140 |
Why?
|
United States | 13 | 2024 | 72363 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 278 | 0.140 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2019 | 243 | 0.130 |
Why?
|
Molecular Epidemiology | 4 | 2019 | 469 | 0.130 |
Why?
|
Lymph Nodes | 2 | 2017 | 3491 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2024 | 3531 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 547 | 0.130 |
Why?
|
Pathology Department, Hospital | 1 | 2015 | 10 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 600 | 0.130 |
Why?
|
Mullerian Ducts | 1 | 2016 | 201 | 0.130 |
Why?
|
Medical History Taking | 1 | 2019 | 773 | 0.120 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 649 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 951 | 0.120 |
Why?
|
Pathology, Clinical | 2 | 2015 | 375 | 0.120 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 370 | 0.120 |
Why?
|
Germ Cells | 3 | 2024 | 635 | 0.120 |
Why?
|
Skin | 1 | 2008 | 4468 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3106 | 0.120 |
Why?
|
Aspirin | 2 | 2017 | 3365 | 0.120 |
Why?
|
Gastric Mucosa | 1 | 1997 | 599 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 731 | 0.120 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2020 | 615 | 0.120 |
Why?
|
Body Composition | 1 | 2023 | 2418 | 0.110 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 194 | 0.110 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2651 | 0.110 |
Why?
|
Rectum | 2 | 2019 | 896 | 0.110 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 193 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 6 | 2022 | 17766 | 0.110 |
Why?
|
Utilization Review | 1 | 2015 | 383 | 0.110 |
Why?
|
Protein Interaction Mapping | 1 | 2017 | 617 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1342 | 0.110 |
Why?
|
Seafood | 1 | 2016 | 390 | 0.110 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 329 | 0.110 |
Why?
|
Oncogenes | 1 | 2019 | 1221 | 0.110 |
Why?
|
Metabolome | 1 | 2020 | 976 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3333 | 0.100 |
Why?
|
Cost Control | 1 | 2015 | 630 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2204 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3903 | 0.100 |
Why?
|
Peptides | 1 | 2024 | 4358 | 0.100 |
Why?
|
Up-Regulation | 2 | 2019 | 4127 | 0.100 |
Why?
|
Risk Factors | 15 | 2024 | 74269 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 917 | 0.100 |
Why?
|
Phagocytosis | 1 | 2017 | 1536 | 0.100 |
Why?
|
Gene Expression Profiling | 4 | 2024 | 9388 | 0.100 |
Why?
|
Alcohol Drinking | 1 | 2024 | 4012 | 0.100 |
Why?
|
Lymph Node Excision | 1 | 2017 | 1305 | 0.090 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2532 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2015 | 724 | 0.090 |
Why?
|
Genomics | 3 | 2024 | 5790 | 0.090 |
Why?
|
Adenoma | 1 | 2021 | 2148 | 0.090 |
Why?
|
Macrophages | 3 | 2023 | 5745 | 0.090 |
Why?
|
Pancreatectomy | 3 | 2020 | 809 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2282 | 0.080 |
Why?
|
MicroRNAs | 2 | 2016 | 3784 | 0.080 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 706 | 0.080 |
Why?
|
Integrin alpha6 | 1 | 2009 | 30 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2007 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1423 | 0.080 |
Why?
|
Aged, 80 and over | 11 | 2024 | 58947 | 0.080 |
Why?
|
Mice | 11 | 2024 | 81216 | 0.080 |
Why?
|
Ubiquitins | 2 | 2000 | 370 | 0.080 |
Why?
|
Multivariate Analysis | 6 | 2017 | 12156 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20048 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2018 | 2633 | 0.080 |
Why?
|
Mitomycin | 1 | 2009 | 262 | 0.080 |
Why?
|
Computational Biology | 2 | 2017 | 3504 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3613 | 0.070 |
Why?
|
High Mobility Group Proteins | 1 | 2008 | 176 | 0.070 |
Why?
|
Alleles | 1 | 2019 | 6900 | 0.070 |
Why?
|
SOX9 Transcription Factor | 1 | 2008 | 145 | 0.070 |
Why?
|
Cohort Studies | 9 | 2021 | 41317 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1651 | 0.070 |
Why?
|
Skin Physiological Phenomena | 1 | 2008 | 189 | 0.070 |
Why?
|
Base Sequence | 2 | 2016 | 12447 | 0.070 |
Why?
|
Cells, Cultured | 4 | 2020 | 18968 | 0.070 |
Why?
|
3T3 Cells | 1 | 2009 | 1085 | 0.070 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2016 | 1387 | 0.070 |
Why?
|
Cannabinoids | 1 | 2009 | 173 | 0.070 |
Why?
|
Antigens, CD34 | 1 | 2009 | 652 | 0.070 |
Why?
|
Flow Cytometry | 3 | 2020 | 5873 | 0.070 |
Why?
|
Obesity | 2 | 2020 | 12915 | 0.070 |
Why?
|
Body Mass Index | 3 | 2020 | 12901 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5884 | 0.070 |
Why?
|
Integrases | 1 | 2008 | 516 | 0.060 |
Why?
|
Calcium | 1 | 2019 | 5726 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2015 | 2909 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2332 | 0.060 |
Why?
|
Pancreas | 2 | 2024 | 1677 | 0.060 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2368 | 0.060 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5784 | 0.060 |
Why?
|
DNA Copy Number Variations | 3 | 2019 | 2008 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2024 | 16905 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12602 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15273 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5640 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3215 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15766 | 0.060 |
Why?
|
Epidemiologic Factors | 1 | 2024 | 36 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2021 | 2866 | 0.060 |
Why?
|
Morphogenesis | 1 | 2008 | 740 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2021 | 9196 | 0.060 |
Why?
|
Bacteroides Infections | 1 | 2024 | 89 | 0.060 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2004 | 84 | 0.060 |
Why?
|
CA-19-9 Antigen | 1 | 2024 | 106 | 0.060 |
Why?
|
Signal Transduction | 3 | 2024 | 23363 | 0.060 |
Why?
|
Animals | 11 | 2024 | 167940 | 0.060 |
Why?
|
Endoplasmic Reticulum | 1 | 2009 | 1135 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2024 | 2536 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2017 | 11480 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6540 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2421 | 0.050 |
Why?
|
bcl-2-Associated X Protein | 1 | 2004 | 282 | 0.050 |
Why?
|
Blood Glucose | 1 | 2017 | 6375 | 0.050 |
Why?
|
Insulin | 1 | 2017 | 6592 | 0.050 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2022 | 61 | 0.050 |
Why?
|
Claudins | 1 | 2023 | 115 | 0.050 |
Why?
|
Allosteric Regulation | 1 | 2023 | 426 | 0.050 |
Why?
|
Sulfur | 1 | 2022 | 163 | 0.050 |
Why?
|
Albumins | 1 | 2024 | 577 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2022 | 240 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 198 | 0.050 |
Why?
|
Biological Availability | 1 | 2022 | 395 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4317 | 0.050 |
Why?
|
Databases, Factual | 4 | 2019 | 8018 | 0.050 |
Why?
|
Intention | 1 | 2024 | 337 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 450 | 0.050 |
Why?
|
Logistic Models | 3 | 2024 | 13311 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2022 | 181 | 0.050 |
Why?
|
Endocrine Cells | 1 | 2020 | 9 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 698 | 0.050 |
Why?
|
DNA Repair | 2 | 2021 | 2039 | 0.040 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2000 | 1858 | 0.040 |
Why?
|
Exocrine Glands | 1 | 2020 | 46 | 0.040 |
Why?
|
Muscular Atrophy | 1 | 2023 | 331 | 0.040 |
Why?
|
Cysteine Endopeptidases | 2 | 2000 | 548 | 0.040 |
Why?
|
Cell Cycle | 1 | 2008 | 2937 | 0.040 |
Why?
|
Vacuoles | 1 | 2000 | 229 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2020 | 2823 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2023 | 568 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 1601 | 0.040 |
Why?
|
Ferritins | 1 | 2022 | 598 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2005 | 1344 | 0.040 |
Why?
|
Multienzyme Complexes | 2 | 2000 | 666 | 0.040 |
Why?
|
Fungal Proteins | 2 | 2000 | 911 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11341 | 0.040 |
Why?
|
Receptors, CXCR3 | 1 | 2020 | 238 | 0.040 |
Why?
|
beta Catenin | 2 | 2020 | 1043 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4875 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2005 | 1755 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 2 | 2000 | 2702 | 0.040 |
Why?
|
Survival Rate | 3 | 2018 | 12806 | 0.040 |
Why?
|
Nurses | 2 | 2019 | 2468 | 0.040 |
Why?
|
MutS Homolog 2 Protein | 1 | 2019 | 195 | 0.040 |
Why?
|
Rectus Abdominis | 1 | 2019 | 103 | 0.040 |
Why?
|
Gene Amplification | 1 | 2023 | 1085 | 0.040 |
Why?
|
ras Proteins | 1 | 2023 | 1051 | 0.040 |
Why?
|
Bacterial Toxins | 1 | 2024 | 931 | 0.040 |
Why?
|
Transcription Factors | 3 | 2022 | 12100 | 0.040 |
Why?
|
Urease | 1 | 1997 | 39 | 0.040 |
Why?
|
Cell Line | 2 | 2020 | 15626 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2019 | 8984 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1155 | 0.040 |
Why?
|
Histological Techniques | 1 | 1997 | 194 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 2018 | 328 | 0.040 |
Why?
|
Health Personnel | 2 | 2024 | 3310 | 0.040 |
Why?
|
Wound Healing | 1 | 2008 | 2786 | 0.040 |
Why?
|
Young Adult | 5 | 2021 | 58673 | 0.040 |
Why?
|
Multigene Family | 1 | 2020 | 1079 | 0.040 |
Why?
|
Colony Count, Microbial | 1 | 1997 | 328 | 0.040 |
Why?
|
Endopeptidases | 1 | 2000 | 772 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1765 | 0.030 |
Why?
|
Proteins | 2 | 2009 | 6030 | 0.030 |
Why?
|
Allergy and Immunology | 1 | 2018 | 175 | 0.030 |
Why?
|
Cell Division | 1 | 2004 | 4462 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 4355 | 0.030 |
Why?
|
Endocytosis | 1 | 2000 | 960 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2009 | 10434 | 0.030 |
Why?
|
Kinetics | 1 | 2004 | 6378 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 962 | 0.030 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22041 | 0.030 |
Why?
|
Problem Solving | 1 | 2018 | 440 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2101 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 659 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2017 | 14396 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9629 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2861 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1115 | 0.030 |
Why?
|
Adolescent | 5 | 2021 | 87747 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2797 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2486 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1122 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2024 | 1892 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2415 | 0.030 |
Why?
|
Organ Specificity | 1 | 2019 | 1955 | 0.030 |
Why?
|
Glioma | 1 | 2009 | 3420 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2442 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.030 |
Why?
|
Pancreaticoduodenectomy | 1 | 2017 | 506 | 0.030 |
Why?
|
Iron | 1 | 2022 | 1786 | 0.030 |
Why?
|
Esophagectomy | 1 | 2018 | 469 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4891 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 607 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3086 | 0.030 |
Why?
|
Dietary Fiber | 1 | 2017 | 760 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2004 | 2927 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2063 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2005 | 6067 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 934 | 0.030 |
Why?
|
Smoking | 2 | 2022 | 9070 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4613 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2721 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2017 | 1008 | 0.030 |
Why?
|
HLA Antigens | 1 | 2018 | 1369 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3011 | 0.030 |
Why?
|
Expert Testimony | 1 | 2015 | 361 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2024 | 64947 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3618 | 0.020 |
Why?
|
Genotype | 2 | 2024 | 12959 | 0.020 |
Why?
|
Apoptosis | 3 | 2017 | 9497 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2017 | 1254 | 0.020 |
Why?
|
Gene Dosage | 1 | 2016 | 1218 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2024 | 3389 | 0.020 |
Why?
|
Epigenomics | 1 | 2017 | 936 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2023 | 3293 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 40133 | 0.020 |
Why?
|
Protein Conformation | 1 | 2019 | 3969 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1483 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2321 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22025 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2609 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2003 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2022 | 80301 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3149 | 0.020 |
Why?
|
Viral Proteins | 1 | 2017 | 1802 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1614 | 0.020 |
Why?
|
Escherichia coli | 1 | 2022 | 4223 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2931 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2023 | 3822 | 0.020 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2009 | 69 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2945 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1740 | 0.020 |
Why?
|
Proteome | 1 | 2019 | 1856 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2009 | 203 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5429 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1589 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12762 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13505 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2017 | 2299 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2009 | 180 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4923 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42034 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 871 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2008 | 532 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 24086 | 0.020 |
Why?
|
Caspase 3 | 1 | 2009 | 730 | 0.020 |
Why?
|
Cause of Death | 1 | 2017 | 3723 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 1447 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3076 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5498 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2017 | 2730 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6775 | 0.020 |
Why?
|
Proteomics | 1 | 2019 | 3810 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7345 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8553 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2819 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2009 | 1078 | 0.010 |
Why?
|
Cell Death | 1 | 2009 | 1670 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2000 | 1314 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9712 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1137 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1120 | 0.010 |
Why?
|
Child | 2 | 2021 | 79758 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11902 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1997 | 14656 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2015 | 3598 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3335 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5695 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1900 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4573 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18134 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2009 | 3584 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10757 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2449 | 0.010 |
Why?
|
Suppression, Genetic | 1 | 2000 | 190 | 0.010 |
Why?
|
Intramolecular Transferases | 1 | 1999 | 15 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2058 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2378 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3774 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36030 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8945 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 2015 | 3217 | 0.010 |
Why?
|
Polyubiquitin | 1 | 1999 | 68 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 6181 | 0.010 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2000 | 150 | 0.010 |
Why?
|
Biopolymers | 1 | 1999 | 185 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3726 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2000 | 13456 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2009 | 2978 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2874 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4312 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8314 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3448 | 0.010 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2000 | 454 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 17628 | 0.010 |
Why?
|
Mutagenesis | 1 | 2000 | 1234 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2000 | 1792 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2755 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2000 | 2178 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20484 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2019 | 21065 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 13967 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 25928 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36247 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9468 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6543 | 0.010 |
Why?
|